Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

16.02
+0.18001.14%
Post-market: 16.480.4600+2.87%19:01 EDT
Volume:508.78K
Turnover:8.14M
Market Cap:824.92M
PE:7.78
High:16.16
Open:15.77
Low:15.73
Close:15.84
52wk High:21.03
52wk Low:7.90
Shares:51.49M
Float Shares:21.84M
Volume Ratio:0.84
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.06
EPS(LYR):2.06
ROE:44.85%
ROA:-0.54%
PB:2.78
PE(LYR):7.78

Loading ...

Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report